CORRECT: FTSE 100 closes up despite "harsh" UK jobs data
(Correcting the closing prices for InterContinental Hotels and Diploma, and replacing easyJet with Anglo American for the biggest fallers on the FTSE 100). Read More
Price | 10,294.00p on 18-07-2025 | at 18:50:05
---|---|
Change | -18.00p -0.17% |
Buy | 10,308.00p |
Sell | 10,304.00p |
Buy / Sell AZN Shares |
Last Trade: | Unknown 55.00 at 10,264.67123p |
Day's Volume: | 1,470,103 |
Last Close: | 10,294.00p |
Open: | 10,294.00p |
ISIN: | GB0009895292 |
Day's Range | 10,234.00p - 10,350.00p |
52wk Range: | 9,574.00p - 13,338.00p |
Market Capitalisation: | £159.58b |
VWAP: | 10,293.84491p |
Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Unknown* | 55 | 10,264.67123p | Currency Conversion Negotiated Trade OTC Trade |
17:32:47 - 18-Jul-25 |
Sell* | 1,773 | 10,284.86p | SI Trade Suspected SELL Trade |
16:56:50 - 18-Jul-25 |
Unknown* | 8 | 10,294.00p | OTC Trade |
16:37:52 - 18-Jul-25 |
Unknown* | 113 | 10,294.00p | OTC Trade |
16:37:52 - 18-Jul-25 |
Unknown* | 4 | 10,294.00p | OTC Trade |
16:37:52 - 18-Jul-25 |
Unknown* | 16 | 10,294.00p | OTC Trade |
16:37:52 - 18-Jul-25 |
Unknown* | 9 | 10,294.00p | OTC Trade |
16:37:52 - 18-Jul-25 |
Buy* | 77 | 10,294.00p | SI Trade Negotiated Trade |
16:36:31 - 18-Jul-25 |
Sell* | 51 | 10,306.00p | Automatic Execution |
16:29:58 - 18-Jul-25 |
Sell* | 24 | 10,306.00p | Automatic Execution |
16:29:58 - 18-Jul-25 |
Astrazeneca (AZN) Regulatory News |
||
Date | Source | Headline |
---|---|---|
16th Jul 2025 7:00 am | RNS | Update on anselamimab in AL amyloidosis |
14th Jul 2025 7:00 am | RNS | Baxdrostat met primary endpt in BaxHTN PhIII trial |
4th Jul 2025 7:00 am | RNS | Imfinzi approved in the EU for bladder cancer |
1st Jul 2025 3:00 pm | RNS | Total Voting Rights |
24th Jun 2025 7:00 am | RNS | Datroway approved in US for EGFRm lung cancer |
17th Jun 2025 11:45 am | RNS | Holding(s) in Company |
13th Jun 2025 9:30 am | RNS | AstraZeneca enters into collaboration with CSPC |
12th Jun 2025 3:00 pm | RNS | Director/PDMR Shareholding |
6th Jun 2025 7:00 am | RNS | Fixed-duration Calquence approved in EU for 1L CLL |
2nd Jun 2025 3:05 pm | RNS | Block listing Interim Review |